nodes	percent_of_prediction	percent_of_DWPC	metapath
Irbesartan—PTGS1—Dapsone—systemic lupus erythematosus	0.0696	0.136	CbGbCtD
Irbesartan—CYP1A2—Leflunomide—systemic lupus erythematosus	0.0436	0.085	CbGbCtD
Irbesartan—CYP2C8—Dapsone—systemic lupus erythematosus	0.0402	0.0782	CbGbCtD
Irbesartan—CYP2C9—Leflunomide—systemic lupus erythematosus	0.0393	0.0766	CbGbCtD
Irbesartan—CYP2C8—Mycophenolate mofetil—systemic lupus erythematosus	0.0348	0.0678	CbGbCtD
Irbesartan—CYP2C9—Dapsone—systemic lupus erythematosus	0.028	0.0546	CbGbCtD
Irbesartan—CYP2C8—Hydrocortisone—systemic lupus erythematosus	0.0279	0.0544	CbGbCtD
Irbesartan—CYP2C8—Cyclosporine—systemic lupus erythematosus	0.0264	0.0514	CbGbCtD
Irbesartan—CYP3A4—Methylprednisolone—systemic lupus erythematosus	0.0186	0.0363	CbGbCtD
Irbesartan—CYP2C9—Cyclosporine—systemic lupus erythematosus	0.0184	0.0359	CbGbCtD
Irbesartan—CYP2C8—Dexamethasone—systemic lupus erythematosus	0.0174	0.0339	CbGbCtD
Irbesartan—CYP2D6—Cyclosporine—systemic lupus erythematosus	0.0168	0.0328	CbGbCtD
Irbesartan—CYP3A4—Dapsone—systemic lupus erythematosus	0.0163	0.0317	CbGbCtD
Irbesartan—CYP3A4—Triamcinolone—systemic lupus erythematosus	0.0141	0.0275	CbGbCtD
Irbesartan—CYP3A4—Mycophenolate mofetil—systemic lupus erythematosus	0.0141	0.0275	CbGbCtD
Irbesartan—CYP2C9—cardial valve—systemic lupus erythematosus	0.0132	0.153	CbGeAlD
Irbesartan—CYP2C9—Dexamethasone—systemic lupus erythematosus	0.0121	0.0236	CbGbCtD
Irbesartan—CYP3A4—Betamethasone—systemic lupus erythematosus	0.0121	0.0236	CbGbCtD
Irbesartan—CYP3A4—Prednisolone—systemic lupus erythematosus	0.012	0.0233	CbGbCtD
Irbesartan—CYP3A4—Hydrocortisone—systemic lupus erythematosus	0.0113	0.0221	CbGbCtD
Irbesartan—CYP3A4—Prednisone—systemic lupus erythematosus	0.0113	0.022	CbGbCtD
Irbesartan—CYP2D6—Dexamethasone—systemic lupus erythematosus	0.0111	0.0216	CbGbCtD
Irbesartan—CYP3A4—Cyclosporine—systemic lupus erythematosus	0.0107	0.0208	CbGbCtD
Irbesartan—CYP3A4—Dexamethasone—systemic lupus erythematosus	0.00705	0.0137	CbGbCtD
Irbesartan—JUN—endothelium—systemic lupus erythematosus	0.00461	0.0536	CbGeAlD
Irbesartan—AGTR1—endothelium—systemic lupus erythematosus	0.00347	0.0404	CbGeAlD
Irbesartan—AGTR1—blood plasma—systemic lupus erythematosus	0.00308	0.0359	CbGeAlD
Irbesartan—CYP1A2—urine—systemic lupus erythematosus	0.003	0.0349	CbGeAlD
Irbesartan—CYP2C9—urine—systemic lupus erythematosus	0.00284	0.0331	CbGeAlD
Irbesartan—JUN—connective tissue—systemic lupus erythematosus	0.00218	0.0254	CbGeAlD
Irbesartan—CYP3A4—urine—systemic lupus erythematosus	0.00217	0.0252	CbGeAlD
Irbesartan—CYP2D6—urine—systemic lupus erythematosus	0.00213	0.0248	CbGeAlD
Irbesartan—JUN—nephron tubule—systemic lupus erythematosus	0.00211	0.0246	CbGeAlD
Irbesartan—EDNRA—cortex of kidney—systemic lupus erythematosus	0.00198	0.023	CbGeAlD
Irbesartan—JUN—skin of body—systemic lupus erythematosus	0.00197	0.0229	CbGeAlD
Irbesartan—JUN—kidney—systemic lupus erythematosus	0.00186	0.0216	CbGeAlD
Irbesartan—JUN—cortex of kidney—systemic lupus erythematosus	0.00181	0.021	CbGeAlD
Irbesartan—CYP2C8—blood plasma—systemic lupus erythematosus	0.00167	0.0194	CbGeAlD
Irbesartan—EDNRA—tendon—systemic lupus erythematosus	0.00164	0.0191	CbGeAlD
Irbesartan—AGTR1—connective tissue—systemic lupus erythematosus	0.00164	0.0191	CbGeAlD
Irbesartan—JUN—lymphoid tissue—systemic lupus erythematosus	0.00159	0.0185	CbGeAlD
Irbesartan—AGTR1—nephron tubule—systemic lupus erythematosus	0.00159	0.0185	CbGeAlD
Irbesartan—CYP1A2—blood plasma—systemic lupus erythematosus	0.00156	0.0182	CbGeAlD
Irbesartan—PTGS1—endothelium—systemic lupus erythematosus	0.00153	0.0178	CbGeAlD
Irbesartan—JUN—tendon—systemic lupus erythematosus	0.0015	0.0174	CbGeAlD
Irbesartan—CYP2C9—blood plasma—systemic lupus erythematosus	0.00148	0.0173	CbGeAlD
Irbesartan—JUN—bone marrow—systemic lupus erythematosus	0.00145	0.0169	CbGeAlD
Irbesartan—EDNRA—lung—systemic lupus erythematosus	0.00144	0.0168	CbGeAlD
Irbesartan—AGTR1—kidney—systemic lupus erythematosus	0.0014	0.0163	CbGeAlD
Irbesartan—AGTR1—cortex of kidney—systemic lupus erythematosus	0.00136	0.0158	CbGeAlD
Irbesartan—PTGS1—blood plasma—systemic lupus erythematosus	0.00136	0.0158	CbGeAlD
Irbesartan—JUN—lung—systemic lupus erythematosus	0.00131	0.0153	CbGeAlD
Irbesartan—JUN—nervous system—systemic lupus erythematosus	0.00122	0.0142	CbGeAlD
Irbesartan—AGTR1—lymphoid tissue—systemic lupus erythematosus	0.0012	0.014	CbGeAlD
Irbesartan—JUN—central nervous system—systemic lupus erythematosus	0.00117	0.0136	CbGeAlD
Irbesartan—CYP3A4—blood plasma—systemic lupus erythematosus	0.00113	0.0132	CbGeAlD
Irbesartan—AGTR1—tendon—systemic lupus erythematosus	0.00113	0.0131	CbGeAlD
Irbesartan—CYP2D6—blood plasma—systemic lupus erythematosus	0.00111	0.013	CbGeAlD
Irbesartan—AGTR1—lung—systemic lupus erythematosus	0.00099	0.0115	CbGeAlD
Irbesartan—AGTR1—nervous system—systemic lupus erythematosus	0.000917	0.0107	CbGeAlD
Irbesartan—AGTR1—central nervous system—systemic lupus erythematosus	0.000883	0.0103	CbGeAlD
Irbesartan—CYP2C8—kidney—systemic lupus erythematosus	0.000757	0.00881	CbGeAlD
Irbesartan—PTGS1—connective tissue—systemic lupus erythematosus	0.000721	0.00839	CbGeAlD
Irbesartan—Losartan—ACE—systemic lupus erythematosus	0.000679	0.445	CrCbGaD
Irbesartan—PTGS1—skin of body—systemic lupus erythematosus	0.000651	0.00758	CbGeAlD
Irbesartan—PTGS1—kidney—systemic lupus erythematosus	0.000614	0.00714	CbGeAlD
Irbesartan—Valsartan—ALB—systemic lupus erythematosus	0.00057	0.373	CrCbGaD
Irbesartan—CYP3A4—kidney—systemic lupus erythematosus	0.000513	0.00597	CbGeAlD
Irbesartan—CYP2D6—kidney—systemic lupus erythematosus	0.000505	0.00587	CbGeAlD
Irbesartan—CYP1A2—lung—systemic lupus erythematosus	0.000502	0.00584	CbGeAlD
Irbesartan—PTGS1—tendon—systemic lupus erythematosus	0.000496	0.00577	CbGeAlD
Irbesartan—JUN—Betamethasone—Hydrocortisone—systemic lupus erythematosus	0.000461	0.0912	CbGdCrCtD
Irbesartan—JUN—Dexamethasone—Hydrocortisone—systemic lupus erythematosus	0.000461	0.0912	CbGdCrCtD
Irbesartan—PTGS1—lung—systemic lupus erythematosus	0.000435	0.00506	CbGeAlD
Irbesartan—JUN—Dexamethasone—Methylprednisolone—systemic lupus erythematosus	0.000435	0.0861	CbGdCrCtD
Irbesartan—JUN—Betamethasone—Methylprednisolone—systemic lupus erythematosus	0.000435	0.0861	CbGdCrCtD
Irbesartan—JUN—Dexamethasone—Betamethasone—systemic lupus erythematosus	0.000428	0.0847	CbGdCrCtD
Irbesartan—JUN—Betamethasone—Dexamethasone—systemic lupus erythematosus	0.000428	0.0847	CbGdCrCtD
Irbesartan—JUN—Dexamethasone—Triamcinolone—systemic lupus erythematosus	0.000418	0.0828	CbGdCrCtD
Irbesartan—JUN—Betamethasone—Triamcinolone—systemic lupus erythematosus	0.000418	0.0828	CbGdCrCtD
Irbesartan—PTGS1—nervous system—systemic lupus erythematosus	0.000403	0.00469	CbGeAlD
Irbesartan—JUN—Betamethasone—Prednisone—systemic lupus erythematosus	0.000397	0.0785	CbGdCrCtD
Irbesartan—JUN—Dexamethasone—Prednisone—systemic lupus erythematosus	0.000397	0.0785	CbGdCrCtD
Irbesartan—PTGS1—central nervous system—systemic lupus erythematosus	0.000388	0.00451	CbGeAlD
Irbesartan—JUN—Betamethasone—Prednisolone—systemic lupus erythematosus	0.000387	0.0767	CbGdCrCtD
Irbesartan—JUN—Dexamethasone—Prednisolone—systemic lupus erythematosus	0.000387	0.0767	CbGdCrCtD
Irbesartan—CYP3A4—nervous system—systemic lupus erythematosus	0.000337	0.00392	CbGeAlD
Irbesartan—CYP2D6—nervous system—systemic lupus erythematosus	0.000331	0.00385	CbGeAlD
Irbesartan—CYP3A4—central nervous system—systemic lupus erythematosus	0.000324	0.00377	CbGeAlD
Irbesartan—CYP2D6—central nervous system—systemic lupus erythematosus	0.000319	0.00371	CbGeAlD
Irbesartan—Losartan—ALB—systemic lupus erythematosus	0.000278	0.182	CrCbGaD
Irbesartan—Decreased appetite—Hydrocortisone—systemic lupus erythematosus	0.000115	0.000496	CcSEcCtD
Irbesartan—Pharyngitis—Methotrexate—systemic lupus erythematosus	0.000115	0.000496	CcSEcCtD
Irbesartan—Abdominal pain—Mycophenolate mofetil—systemic lupus erythematosus	0.000115	0.000495	CcSEcCtD
Irbesartan—Body temperature increased—Mycophenolate mofetil—systemic lupus erythematosus	0.000115	0.000495	CcSEcCtD
Irbesartan—Nausea—Leflunomide—systemic lupus erythematosus	0.000114	0.000494	CcSEcCtD
Irbesartan—Urinary tract disorder—Methotrexate—systemic lupus erythematosus	0.000114	0.000493	CcSEcCtD
Irbesartan—Gastrointestinal disorder—Hydrocortisone—systemic lupus erythematosus	0.000114	0.000493	CcSEcCtD
Irbesartan—Fatigue—Hydrocortisone—systemic lupus erythematosus	0.000114	0.000492	CcSEcCtD
Irbesartan—Vision blurred—Prednisone—systemic lupus erythematosus	0.000113	0.00049	CcSEcCtD
Irbesartan—Urethral disorder—Methotrexate—systemic lupus erythematosus	0.000113	0.000489	CcSEcCtD
Irbesartan—Musculoskeletal discomfort—Triamcinolone—systemic lupus erythematosus	0.000113	0.000489	CcSEcCtD
Irbesartan—Musculoskeletal discomfort—Methylprednisolone—systemic lupus erythematosus	0.000113	0.000488	CcSEcCtD
Irbesartan—Pain—Hydrocortisone—systemic lupus erythematosus	0.000113	0.000488	CcSEcCtD
Irbesartan—Anaphylactic shock—Dexamethasone—systemic lupus erythematosus	0.000113	0.000487	CcSEcCtD
Irbesartan—Oedema—Dexamethasone—systemic lupus erythematosus	0.000113	0.000487	CcSEcCtD
Irbesartan—Anaphylactic shock—Betamethasone—systemic lupus erythematosus	0.000113	0.000487	CcSEcCtD
Irbesartan—Oedema—Betamethasone—systemic lupus erythematosus	0.000113	0.000487	CcSEcCtD
Irbesartan—Infection—Betamethasone—systemic lupus erythematosus	0.000112	0.000484	CcSEcCtD
Irbesartan—Infection—Dexamethasone—systemic lupus erythematosus	0.000112	0.000484	CcSEcCtD
Irbesartan—Ill-defined disorder—Prednisone—systemic lupus erythematosus	0.000112	0.000483	CcSEcCtD
Irbesartan—Paraesthesia—Triamcinolone—systemic lupus erythematosus	0.000112	0.000482	CcSEcCtD
Irbesartan—Feeling abnormal—Prednisolone—systemic lupus erythematosus	0.000111	0.000481	CcSEcCtD
Irbesartan—Paraesthesia—Methylprednisolone—systemic lupus erythematosus	0.000111	0.000481	CcSEcCtD
Irbesartan—Visual impairment—Methotrexate—systemic lupus erythematosus	0.000111	0.000481	CcSEcCtD
Irbesartan—Anaemia—Prednisone—systemic lupus erythematosus	0.000111	0.000481	CcSEcCtD
Irbesartan—Shock—Dexamethasone—systemic lupus erythematosus	0.000111	0.00048	CcSEcCtD
Irbesartan—Shock—Betamethasone—systemic lupus erythematosus	0.000111	0.00048	CcSEcCtD
Irbesartan—Dyspnoea—Triamcinolone—systemic lupus erythematosus	0.000111	0.000479	CcSEcCtD
Irbesartan—Nervous system disorder—Betamethasone—systemic lupus erythematosus	0.000111	0.000478	CcSEcCtD
Irbesartan—Nervous system disorder—Dexamethasone—systemic lupus erythematosus	0.000111	0.000478	CcSEcCtD
Irbesartan—Agitation—Prednisone—systemic lupus erythematosus	0.000111	0.000478	CcSEcCtD
Irbesartan—Thrombocytopenia—Betamethasone—systemic lupus erythematosus	0.00011	0.000477	CcSEcCtD
Irbesartan—Thrombocytopenia—Dexamethasone—systemic lupus erythematosus	0.00011	0.000477	CcSEcCtD
Irbesartan—Tachycardia—Betamethasone—systemic lupus erythematosus	0.00011	0.000476	CcSEcCtD
Irbesartan—Tachycardia—Dexamethasone—systemic lupus erythematosus	0.00011	0.000476	CcSEcCtD
Irbesartan—Angioedema—Prednisone—systemic lupus erythematosus	0.00011	0.000475	CcSEcCtD
Irbesartan—Hypersensitivity—Cyclosporine—systemic lupus erythematosus	0.000109	0.000473	CcSEcCtD
Irbesartan—Dyspepsia—Triamcinolone—systemic lupus erythematosus	0.000109	0.000473	CcSEcCtD
Irbesartan—Dyspepsia—Methylprednisolone—systemic lupus erythematosus	0.000109	0.000472	CcSEcCtD
Irbesartan—Hyperhidrosis—Betamethasone—systemic lupus erythematosus	0.000109	0.000471	CcSEcCtD
Irbesartan—Hyperhidrosis—Dexamethasone—systemic lupus erythematosus	0.000109	0.000471	CcSEcCtD
Irbesartan—Feeling abnormal—Hydrocortisone—systemic lupus erythematosus	0.000109	0.00047	CcSEcCtD
Irbesartan—Malaise—Prednisone—systemic lupus erythematosus	0.000109	0.000469	CcSEcCtD
Irbesartan—Vertigo—Prednisone—systemic lupus erythematosus	0.000108	0.000467	CcSEcCtD
Irbesartan—Gastrointestinal pain—Hydrocortisone—systemic lupus erythematosus	0.000108	0.000467	CcSEcCtD
Irbesartan—Syncope—Prednisone—systemic lupus erythematosus	0.000108	0.000466	CcSEcCtD
Irbesartan—Tinnitus—Methotrexate—systemic lupus erythematosus	0.000108	0.000466	CcSEcCtD
Irbesartan—Anorexia—Dexamethasone—systemic lupus erythematosus	0.000107	0.000465	CcSEcCtD
Irbesartan—Anorexia—Betamethasone—systemic lupus erythematosus	0.000107	0.000465	CcSEcCtD
Irbesartan—Urticaria—Prednisolone—systemic lupus erythematosus	0.000107	0.000464	CcSEcCtD
Irbesartan—Cardiac disorder—Methotrexate—systemic lupus erythematosus	0.000107	0.000463	CcSEcCtD
Irbesartan—Fatigue—Triamcinolone—systemic lupus erythematosus	0.000107	0.000463	CcSEcCtD
Irbesartan—Fatigue—Methylprednisolone—systemic lupus erythematosus	0.000107	0.000462	CcSEcCtD
Irbesartan—Hypersensitivity—Mycophenolate mofetil—systemic lupus erythematosus	0.000107	0.000461	CcSEcCtD
Irbesartan—Asthenia—Cyclosporine—systemic lupus erythematosus	0.000107	0.000461	CcSEcCtD
Irbesartan—Pain—Triamcinolone—systemic lupus erythematosus	0.000106	0.000459	CcSEcCtD
Irbesartan—Loss of consciousness—Prednisone—systemic lupus erythematosus	0.000106	0.000457	CcSEcCtD
Irbesartan—Hypotension—Dexamethasone—systemic lupus erythematosus	0.000105	0.000455	CcSEcCtD
Irbesartan—Hypotension—Betamethasone—systemic lupus erythematosus	0.000105	0.000455	CcSEcCtD
Irbesartan—Pruritus—Cyclosporine—systemic lupus erythematosus	0.000105	0.000454	CcSEcCtD
Irbesartan—Urticaria—Hydrocortisone—systemic lupus erythematosus	0.000105	0.000453	CcSEcCtD
Irbesartan—Angiopathy—Methotrexate—systemic lupus erythematosus	0.000105	0.000453	CcSEcCtD
Irbesartan—Immune system disorder—Methotrexate—systemic lupus erythematosus	0.000104	0.000451	CcSEcCtD
Irbesartan—Abdominal pain—Hydrocortisone—systemic lupus erythematosus	0.000104	0.000451	CcSEcCtD
Irbesartan—Body temperature increased—Hydrocortisone—systemic lupus erythematosus	0.000104	0.000451	CcSEcCtD
Irbesartan—Mediastinal disorder—Methotrexate—systemic lupus erythematosus	0.000104	0.00045	CcSEcCtD
Irbesartan—Asthenia—Mycophenolate mofetil—systemic lupus erythematosus	0.000104	0.000449	CcSEcCtD
Irbesartan—Hypertension—Prednisone—systemic lupus erythematosus	0.000104	0.000449	CcSEcCtD
Irbesartan—Chills—Methotrexate—systemic lupus erythematosus	0.000104	0.000448	CcSEcCtD
Irbesartan—Musculoskeletal discomfort—Betamethasone—systemic lupus erythematosus	0.000103	0.000444	CcSEcCtD
Irbesartan—Musculoskeletal discomfort—Dexamethasone—systemic lupus erythematosus	0.000103	0.000444	CcSEcCtD
Irbesartan—Pruritus—Mycophenolate mofetil—systemic lupus erythematosus	0.000102	0.000443	CcSEcCtD
Irbesartan—Myalgia—Prednisone—systemic lupus erythematosus	0.000102	0.000443	CcSEcCtD
Irbesartan—Arthralgia—Prednisone—systemic lupus erythematosus	0.000102	0.000443	CcSEcCtD
Irbesartan—Feeling abnormal—Triamcinolone—systemic lupus erythematosus	0.000102	0.000443	CcSEcCtD
Irbesartan—Feeling abnormal—Methylprednisolone—systemic lupus erythematosus	0.000102	0.000442	CcSEcCtD
Irbesartan—Anxiety—Prednisone—systemic lupus erythematosus	0.000102	0.000441	CcSEcCtD
Irbesartan—Unspecified disorder of skin and subcutaneous tissue—Prednisone—systemic lupus erythematosus	0.000102	0.00044	CcSEcCtD
Irbesartan—Diarrhoea—Cyclosporine—systemic lupus erythematosus	0.000102	0.000439	CcSEcCtD
Irbesartan—Gastrointestinal pain—Methylprednisolone—systemic lupus erythematosus	0.000101	0.000438	CcSEcCtD
Irbesartan—Paraesthesia—Betamethasone—systemic lupus erythematosus	0.000101	0.000438	CcSEcCtD
Irbesartan—Paraesthesia—Dexamethasone—systemic lupus erythematosus	0.000101	0.000438	CcSEcCtD
Irbesartan—Discomfort—Prednisone—systemic lupus erythematosus	0.000101	0.000438	CcSEcCtD
Irbesartan—Erythema—Methotrexate—systemic lupus erythematosus	0.000101	0.000435	CcSEcCtD
Irbesartan—Malnutrition—Methotrexate—systemic lupus erythematosus	0.000101	0.000435	CcSEcCtD
Irbesartan—Hypersensitivity—Prednisolone—systemic lupus erythematosus	9.96e-05	0.00043	CcSEcCtD
Irbesartan—Dyspepsia—Dexamethasone—systemic lupus erythematosus	9.93e-05	0.000429	CcSEcCtD
Irbesartan—Dyspepsia—Betamethasone—systemic lupus erythematosus	9.93e-05	0.000429	CcSEcCtD
Irbesartan—Diarrhoea—Mycophenolate mofetil—systemic lupus erythematosus	9.91e-05	0.000428	CcSEcCtD
Irbesartan—Urticaria—Triamcinolone—systemic lupus erythematosus	9.87e-05	0.000427	CcSEcCtD
Irbesartan—Urticaria—Methylprednisolone—systemic lupus erythematosus	9.85e-05	0.000426	CcSEcCtD
Irbesartan—Dysgeusia—Methotrexate—systemic lupus erythematosus	9.85e-05	0.000426	CcSEcCtD
Irbesartan—Body temperature increased—Triamcinolone—systemic lupus erythematosus	9.82e-05	0.000425	CcSEcCtD
Irbesartan—Dizziness—Cyclosporine—systemic lupus erythematosus	9.82e-05	0.000425	CcSEcCtD
Irbesartan—Anaphylactic shock—Prednisone—systemic lupus erythematosus	9.82e-05	0.000425	CcSEcCtD
Irbesartan—Oedema—Prednisone—systemic lupus erythematosus	9.82e-05	0.000425	CcSEcCtD
Irbesartan—Abdominal pain—Methylprednisolone—systemic lupus erythematosus	9.8e-05	0.000424	CcSEcCtD
Irbesartan—Decreased appetite—Dexamethasone—systemic lupus erythematosus	9.8e-05	0.000424	CcSEcCtD
Irbesartan—Decreased appetite—Betamethasone—systemic lupus erythematosus	9.8e-05	0.000424	CcSEcCtD
Irbesartan—Infection—Prednisone—systemic lupus erythematosus	9.76e-05	0.000422	CcSEcCtD
Irbesartan—Gastrointestinal disorder—Betamethasone—systemic lupus erythematosus	9.74e-05	0.000421	CcSEcCtD
Irbesartan—Gastrointestinal disorder—Dexamethasone—systemic lupus erythematosus	9.74e-05	0.000421	CcSEcCtD
Irbesartan—Hypersensitivity—Hydrocortisone—systemic lupus erythematosus	9.72e-05	0.00042	CcSEcCtD
Irbesartan—Fatigue—Dexamethasone—systemic lupus erythematosus	9.72e-05	0.00042	CcSEcCtD
Irbesartan—Fatigue—Betamethasone—systemic lupus erythematosus	9.72e-05	0.00042	CcSEcCtD
Irbesartan—Shock—Prednisone—systemic lupus erythematosus	9.66e-05	0.000418	CcSEcCtD
Irbesartan—Pain—Dexamethasone—systemic lupus erythematosus	9.64e-05	0.000417	CcSEcCtD
Irbesartan—Pain—Betamethasone—systemic lupus erythematosus	9.64e-05	0.000417	CcSEcCtD
Irbesartan—Nervous system disorder—Prednisone—systemic lupus erythematosus	9.63e-05	0.000416	CcSEcCtD
Irbesartan—Tachycardia—Prednisone—systemic lupus erythematosus	9.58e-05	0.000414	CcSEcCtD
Irbesartan—Dizziness—Mycophenolate mofetil—systemic lupus erythematosus	9.58e-05	0.000414	CcSEcCtD
Irbesartan—Skin disorder—Prednisone—systemic lupus erythematosus	9.54e-05	0.000412	CcSEcCtD
Irbesartan—Hyperhidrosis—Prednisone—systemic lupus erythematosus	9.49e-05	0.00041	CcSEcCtD
Irbesartan—Vision blurred—Methotrexate—systemic lupus erythematosus	9.48e-05	0.00041	CcSEcCtD
Irbesartan—Asthenia—Hydrocortisone—systemic lupus erythematosus	9.47e-05	0.000409	CcSEcCtD
Irbesartan—Vomiting—Cyclosporine—systemic lupus erythematosus	9.44e-05	0.000408	CcSEcCtD
Irbesartan—Rash—Cyclosporine—systemic lupus erythematosus	9.36e-05	0.000405	CcSEcCtD
Irbesartan—Anorexia—Prednisone—systemic lupus erythematosus	9.36e-05	0.000405	CcSEcCtD
Irbesartan—Dermatitis—Cyclosporine—systemic lupus erythematosus	9.35e-05	0.000404	CcSEcCtD
Irbesartan—Pruritus—Hydrocortisone—systemic lupus erythematosus	9.34e-05	0.000404	CcSEcCtD
Irbesartan—Ill-defined disorder—Methotrexate—systemic lupus erythematosus	9.33e-05	0.000403	CcSEcCtD
Irbesartan—Headache—Cyclosporine—systemic lupus erythematosus	9.3e-05	0.000402	CcSEcCtD
Irbesartan—Anaemia—Methotrexate—systemic lupus erythematosus	9.29e-05	0.000402	CcSEcCtD
Irbesartan—Feeling abnormal—Dexamethasone—systemic lupus erythematosus	9.29e-05	0.000402	CcSEcCtD
Irbesartan—Feeling abnormal—Betamethasone—systemic lupus erythematosus	9.29e-05	0.000402	CcSEcCtD
Irbesartan—Gastrointestinal pain—Dexamethasone—systemic lupus erythematosus	9.22e-05	0.000399	CcSEcCtD
Irbesartan—Gastrointestinal pain—Betamethasone—systemic lupus erythematosus	9.22e-05	0.000399	CcSEcCtD
Irbesartan—Vomiting—Mycophenolate mofetil—systemic lupus erythematosus	9.21e-05	0.000398	CcSEcCtD
Irbesartan—Hypersensitivity—Triamcinolone—systemic lupus erythematosus	9.16e-05	0.000396	CcSEcCtD
Irbesartan—Hypersensitivity—Methylprednisolone—systemic lupus erythematosus	9.14e-05	0.000395	CcSEcCtD
Irbesartan—Rash—Mycophenolate mofetil—systemic lupus erythematosus	9.13e-05	0.000395	CcSEcCtD
Irbesartan—Dermatitis—Mycophenolate mofetil—systemic lupus erythematosus	9.13e-05	0.000394	CcSEcCtD
Irbesartan—Headache—Mycophenolate mofetil—systemic lupus erythematosus	9.08e-05	0.000392	CcSEcCtD
Irbesartan—Malaise—Methotrexate—systemic lupus erythematosus	9.07e-05	0.000392	CcSEcCtD
Irbesartan—Vertigo—Methotrexate—systemic lupus erythematosus	9.03e-05	0.000391	CcSEcCtD
Irbesartan—Diarrhoea—Hydrocortisone—systemic lupus erythematosus	9.03e-05	0.00039	CcSEcCtD
Irbesartan—Leukopenia—Methotrexate—systemic lupus erythematosus	9e-05	0.000389	CcSEcCtD
Irbesartan—Urticaria—Dexamethasone—systemic lupus erythematosus	8.96e-05	0.000387	CcSEcCtD
Irbesartan—Urticaria—Betamethasone—systemic lupus erythematosus	8.96e-05	0.000387	CcSEcCtD
Irbesartan—Musculoskeletal discomfort—Prednisone—systemic lupus erythematosus	8.95e-05	0.000387	CcSEcCtD
Irbesartan—Dizziness—Prednisolone—systemic lupus erythematosus	8.94e-05	0.000386	CcSEcCtD
Irbesartan—Asthenia—Triamcinolone—systemic lupus erythematosus	8.92e-05	0.000385	CcSEcCtD
Irbesartan—Body temperature increased—Dexamethasone—systemic lupus erythematosus	8.91e-05	0.000385	CcSEcCtD
Irbesartan—Abdominal pain—Betamethasone—systemic lupus erythematosus	8.91e-05	0.000385	CcSEcCtD
Irbesartan—Abdominal pain—Dexamethasone—systemic lupus erythematosus	8.91e-05	0.000385	CcSEcCtD
Irbesartan—Body temperature increased—Betamethasone—systemic lupus erythematosus	8.91e-05	0.000385	CcSEcCtD
Irbesartan—Asthenia—Methylprednisolone—systemic lupus erythematosus	8.9e-05	0.000385	CcSEcCtD
Irbesartan—Nausea—Cyclosporine—systemic lupus erythematosus	8.82e-05	0.000381	CcSEcCtD
Irbesartan—Paraesthesia—Prednisone—systemic lupus erythematosus	8.82e-05	0.000381	CcSEcCtD
Irbesartan—Pruritus—Triamcinolone—systemic lupus erythematosus	8.79e-05	0.00038	CcSEcCtD
Irbesartan—Cough—Methotrexate—systemic lupus erythematosus	8.77e-05	0.000379	CcSEcCtD
Irbesartan—Pruritus—Methylprednisolone—systemic lupus erythematosus	8.77e-05	0.000379	CcSEcCtD
Irbesartan—Dizziness—Hydrocortisone—systemic lupus erythematosus	8.73e-05	0.000377	CcSEcCtD
Irbesartan—Dyspepsia—Prednisone—systemic lupus erythematosus	8.64e-05	0.000374	CcSEcCtD
Irbesartan—Nausea—Mycophenolate mofetil—systemic lupus erythematosus	8.61e-05	0.000372	CcSEcCtD
Irbesartan—Chest pain—Methotrexate—systemic lupus erythematosus	8.56e-05	0.00037	CcSEcCtD
Irbesartan—Myalgia—Methotrexate—systemic lupus erythematosus	8.56e-05	0.00037	CcSEcCtD
Irbesartan—Arthralgia—Methotrexate—systemic lupus erythematosus	8.56e-05	0.00037	CcSEcCtD
Irbesartan—Decreased appetite—Prednisone—systemic lupus erythematosus	8.54e-05	0.000369	CcSEcCtD
Irbesartan—Rash—Prednisolone—systemic lupus erythematosus	8.52e-05	0.000368	CcSEcCtD
Irbesartan—Dermatitis—Prednisolone—systemic lupus erythematosus	8.51e-05	0.000368	CcSEcCtD
Irbesartan—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—systemic lupus erythematosus	8.5e-05	0.000368	CcSEcCtD
Irbesartan—Diarrhoea—Methylprednisolone—systemic lupus erythematosus	8.48e-05	0.000367	CcSEcCtD
Irbesartan—Fatigue—Prednisone—systemic lupus erythematosus	8.47e-05	0.000366	CcSEcCtD
Irbesartan—Headache—Prednisolone—systemic lupus erythematosus	8.47e-05	0.000366	CcSEcCtD
Irbesartan—Discomfort—Methotrexate—systemic lupus erythematosus	8.46e-05	0.000366	CcSEcCtD
Irbesartan—Constipation—Prednisone—systemic lupus erythematosus	8.4e-05	0.000363	CcSEcCtD
Irbesartan—Vomiting—Hydrocortisone—systemic lupus erythematosus	8.39e-05	0.000363	CcSEcCtD
Irbesartan—Rash—Hydrocortisone—systemic lupus erythematosus	8.32e-05	0.00036	CcSEcCtD
Irbesartan—Dermatitis—Hydrocortisone—systemic lupus erythematosus	8.31e-05	0.000359	CcSEcCtD
Irbesartan—Headache—Hydrocortisone—systemic lupus erythematosus	8.27e-05	0.000357	CcSEcCtD
Irbesartan—Dizziness—Triamcinolone—systemic lupus erythematosus	8.22e-05	0.000355	CcSEcCtD
Irbesartan—Anaphylactic shock—Methotrexate—systemic lupus erythematosus	8.21e-05	0.000355	CcSEcCtD
Irbesartan—Dizziness—Methylprednisolone—systemic lupus erythematosus	8.2e-05	0.000354	CcSEcCtD
Irbesartan—Infection—Methotrexate—systemic lupus erythematosus	8.15e-05	0.000352	CcSEcCtD
Irbesartan—Feeling abnormal—Prednisone—systemic lupus erythematosus	8.09e-05	0.00035	CcSEcCtD
Irbesartan—Asthenia—Dexamethasone—systemic lupus erythematosus	8.09e-05	0.00035	CcSEcCtD
Irbesartan—Asthenia—Betamethasone—systemic lupus erythematosus	8.09e-05	0.00035	CcSEcCtD
Irbesartan—Nervous system disorder—Methotrexate—systemic lupus erythematosus	8.05e-05	0.000348	CcSEcCtD
Irbesartan—Thrombocytopenia—Methotrexate—systemic lupus erythematosus	8.04e-05	0.000347	CcSEcCtD
Irbesartan—Gastrointestinal pain—Prednisone—systemic lupus erythematosus	8.03e-05	0.000347	CcSEcCtD
Irbesartan—Nausea—Prednisolone—systemic lupus erythematosus	8.03e-05	0.000347	CcSEcCtD
Irbesartan—Pruritus—Betamethasone—systemic lupus erythematosus	7.98e-05	0.000345	CcSEcCtD
Irbesartan—Pruritus—Dexamethasone—systemic lupus erythematosus	7.98e-05	0.000345	CcSEcCtD
Irbesartan—Skin disorder—Methotrexate—systemic lupus erythematosus	7.97e-05	0.000345	CcSEcCtD
Irbesartan—Hyperhidrosis—Methotrexate—systemic lupus erythematosus	7.93e-05	0.000343	CcSEcCtD
Irbesartan—Vomiting—Triamcinolone—systemic lupus erythematosus	7.9e-05	0.000342	CcSEcCtD
Irbesartan—Vomiting—Methylprednisolone—systemic lupus erythematosus	7.88e-05	0.000341	CcSEcCtD
Irbesartan—Nausea—Hydrocortisone—systemic lupus erythematosus	7.84e-05	0.000339	CcSEcCtD
Irbesartan—Rash—Triamcinolone—systemic lupus erythematosus	7.84e-05	0.000339	CcSEcCtD
Irbesartan—Dermatitis—Triamcinolone—systemic lupus erythematosus	7.83e-05	0.000338	CcSEcCtD
Irbesartan—Anorexia—Methotrexate—systemic lupus erythematosus	7.82e-05	0.000338	CcSEcCtD
Irbesartan—Rash—Methylprednisolone—systemic lupus erythematosus	7.82e-05	0.000338	CcSEcCtD
Irbesartan—Dermatitis—Methylprednisolone—systemic lupus erythematosus	7.81e-05	0.000338	CcSEcCtD
Irbesartan—Urticaria—Prednisone—systemic lupus erythematosus	7.8e-05	0.000337	CcSEcCtD
Irbesartan—Headache—Triamcinolone—systemic lupus erythematosus	7.79e-05	0.000337	CcSEcCtD
Irbesartan—Headache—Methylprednisolone—systemic lupus erythematosus	7.77e-05	0.000336	CcSEcCtD
Irbesartan—Body temperature increased—Prednisone—systemic lupus erythematosus	7.76e-05	0.000336	CcSEcCtD
Irbesartan—Abdominal pain—Prednisone—systemic lupus erythematosus	7.76e-05	0.000336	CcSEcCtD
Irbesartan—Diarrhoea—Betamethasone—systemic lupus erythematosus	7.72e-05	0.000334	CcSEcCtD
Irbesartan—Diarrhoea—Dexamethasone—systemic lupus erythematosus	7.72e-05	0.000334	CcSEcCtD
Irbesartan—Hypotension—Methotrexate—systemic lupus erythematosus	7.67e-05	0.000332	CcSEcCtD
Irbesartan—Musculoskeletal discomfort—Methotrexate—systemic lupus erythematosus	7.48e-05	0.000323	CcSEcCtD
Irbesartan—Dizziness—Betamethasone—systemic lupus erythematosus	7.46e-05	0.000322	CcSEcCtD
Irbesartan—Dizziness—Dexamethasone—systemic lupus erythematosus	7.46e-05	0.000322	CcSEcCtD
Irbesartan—Nausea—Triamcinolone—systemic lupus erythematosus	7.38e-05	0.000319	CcSEcCtD
Irbesartan—Paraesthesia—Methotrexate—systemic lupus erythematosus	7.37e-05	0.000319	CcSEcCtD
Irbesartan—Nausea—Methylprednisolone—systemic lupus erythematosus	7.37e-05	0.000318	CcSEcCtD
Irbesartan—Dyspnoea—Methotrexate—systemic lupus erythematosus	7.32e-05	0.000316	CcSEcCtD
Irbesartan—Somnolence—Methotrexate—systemic lupus erythematosus	7.3e-05	0.000315	CcSEcCtD
Irbesartan—Hypersensitivity—Prednisone—systemic lupus erythematosus	7.23e-05	0.000313	CcSEcCtD
Irbesartan—Dyspepsia—Methotrexate—systemic lupus erythematosus	7.22e-05	0.000312	CcSEcCtD
Irbesartan—Vomiting—Dexamethasone—systemic lupus erythematosus	7.17e-05	0.00031	CcSEcCtD
Irbesartan—Vomiting—Betamethasone—systemic lupus erythematosus	7.17e-05	0.00031	CcSEcCtD
Irbesartan—Decreased appetite—Methotrexate—systemic lupus erythematosus	7.13e-05	0.000308	CcSEcCtD
Irbesartan—Rash—Dexamethasone—systemic lupus erythematosus	7.11e-05	0.000307	CcSEcCtD
Irbesartan—Rash—Betamethasone—systemic lupus erythematosus	7.11e-05	0.000307	CcSEcCtD
Irbesartan—Dermatitis—Dexamethasone—systemic lupus erythematosus	7.1e-05	0.000307	CcSEcCtD
Irbesartan—Dermatitis—Betamethasone—systemic lupus erythematosus	7.1e-05	0.000307	CcSEcCtD
Irbesartan—Gastrointestinal disorder—Methotrexate—systemic lupus erythematosus	7.09e-05	0.000306	CcSEcCtD
Irbesartan—Fatigue—Methotrexate—systemic lupus erythematosus	7.08e-05	0.000306	CcSEcCtD
Irbesartan—Headache—Dexamethasone—systemic lupus erythematosus	7.06e-05	0.000305	CcSEcCtD
Irbesartan—Headache—Betamethasone—systemic lupus erythematosus	7.06e-05	0.000305	CcSEcCtD
Irbesartan—Asthenia—Prednisone—systemic lupus erythematosus	7.05e-05	0.000305	CcSEcCtD
Irbesartan—Pain—Methotrexate—systemic lupus erythematosus	7.02e-05	0.000303	CcSEcCtD
Irbesartan—Pruritus—Prednisone—systemic lupus erythematosus	6.95e-05	0.0003	CcSEcCtD
Irbesartan—Feeling abnormal—Methotrexate—systemic lupus erythematosus	6.76e-05	0.000292	CcSEcCtD
Irbesartan—Diarrhoea—Prednisone—systemic lupus erythematosus	6.72e-05	0.00029	CcSEcCtD
Irbesartan—Gastrointestinal pain—Methotrexate—systemic lupus erythematosus	6.71e-05	0.00029	CcSEcCtD
Irbesartan—Nausea—Dexamethasone—systemic lupus erythematosus	6.7e-05	0.00029	CcSEcCtD
Irbesartan—Nausea—Betamethasone—systemic lupus erythematosus	6.7e-05	0.00029	CcSEcCtD
Irbesartan—Urticaria—Methotrexate—systemic lupus erythematosus	6.52e-05	0.000282	CcSEcCtD
Irbesartan—Dizziness—Prednisone—systemic lupus erythematosus	6.49e-05	0.000281	CcSEcCtD
Irbesartan—Abdominal pain—Methotrexate—systemic lupus erythematosus	6.49e-05	0.00028	CcSEcCtD
Irbesartan—Body temperature increased—Methotrexate—systemic lupus erythematosus	6.49e-05	0.00028	CcSEcCtD
Irbesartan—Vomiting—Prednisone—systemic lupus erythematosus	6.24e-05	0.00027	CcSEcCtD
Irbesartan—Rash—Prednisone—systemic lupus erythematosus	6.19e-05	0.000268	CcSEcCtD
Irbesartan—Dermatitis—Prednisone—systemic lupus erythematosus	6.19e-05	0.000267	CcSEcCtD
Irbesartan—Headache—Prednisone—systemic lupus erythematosus	6.15e-05	0.000266	CcSEcCtD
Irbesartan—Hypersensitivity—Methotrexate—systemic lupus erythematosus	6.05e-05	0.000261	CcSEcCtD
Irbesartan—Asthenia—Methotrexate—systemic lupus erythematosus	5.89e-05	0.000255	CcSEcCtD
Irbesartan—Nausea—Prednisone—systemic lupus erythematosus	5.83e-05	0.000252	CcSEcCtD
Irbesartan—Pruritus—Methotrexate—systemic lupus erythematosus	5.81e-05	0.000251	CcSEcCtD
Irbesartan—Diarrhoea—Methotrexate—systemic lupus erythematosus	5.62e-05	0.000243	CcSEcCtD
Irbesartan—Dizziness—Methotrexate—systemic lupus erythematosus	5.43e-05	0.000235	CcSEcCtD
Irbesartan—Vomiting—Methotrexate—systemic lupus erythematosus	5.22e-05	0.000226	CcSEcCtD
Irbesartan—Rash—Methotrexate—systemic lupus erythematosus	5.17e-05	0.000224	CcSEcCtD
Irbesartan—Dermatitis—Methotrexate—systemic lupus erythematosus	5.17e-05	0.000223	CcSEcCtD
Irbesartan—Headache—Methotrexate—systemic lupus erythematosus	5.14e-05	0.000222	CcSEcCtD
Irbesartan—EDNRA—GPCR downstream signaling—C3—systemic lupus erythematosus	4.9e-05	0.000301	CbGpPWpGaD
Irbesartan—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—systemic lupus erythematosus	4.88e-05	0.0003	CbGpPWpGaD
Irbesartan—EDNRA—Signaling Pathways—LYN—systemic lupus erythematosus	4.88e-05	0.0003	CbGpPWpGaD
Irbesartan—Nausea—Methotrexate—systemic lupus erythematosus	4.87e-05	0.000211	CcSEcCtD
Irbesartan—JUN—Immune System—CSK—systemic lupus erythematosus	4.87e-05	0.000299	CbGpPWpGaD
Irbesartan—AGTR1—Signaling by GPCR—RASGRP1—systemic lupus erythematosus	4.86e-05	0.000299	CbGpPWpGaD
Irbesartan—JUN—Immune System—MBL2—systemic lupus erythematosus	4.83e-05	0.000297	CbGpPWpGaD
Irbesartan—EDNRA—Signaling by GPCR—JAK1—systemic lupus erythematosus	4.81e-05	0.000295	CbGpPWpGaD
Irbesartan—JUN—Immune System—IRF5—systemic lupus erythematosus	4.79e-05	0.000294	CbGpPWpGaD
Irbesartan—EDNRA—Signaling Pathways—SH2B3—systemic lupus erythematosus	4.79e-05	0.000294	CbGpPWpGaD
Irbesartan—JUN—MAPK Signaling Pathway—TNF—systemic lupus erythematosus	4.73e-05	0.000291	CbGpPWpGaD
Irbesartan—AGTR1—Signaling Pathways—TLR9—systemic lupus erythematosus	4.73e-05	0.00029	CbGpPWpGaD
Irbesartan—JUN—Cellular responses to stress—CDKN1B—systemic lupus erythematosus	4.62e-05	0.000284	CbGpPWpGaD
Irbesartan—AGTR1—Signaling Pathways—P2RY12—systemic lupus erythematosus	4.58e-05	0.000281	CbGpPWpGaD
Irbesartan—JUN—Immune System—CD247—systemic lupus erythematosus	4.58e-05	0.000281	CbGpPWpGaD
Irbesartan—JUN—Immune System—IRF8—systemic lupus erythematosus	4.58e-05	0.000281	CbGpPWpGaD
Irbesartan—JUN—Immune System—ITGAM—systemic lupus erythematosus	4.58e-05	0.000281	CbGpPWpGaD
Irbesartan—JUN—Immune System—IFIH1—systemic lupus erythematosus	4.58e-05	0.000281	CbGpPWpGaD
Irbesartan—JUN—Integrated Pancreatic Cancer Pathway—TGFB1—systemic lupus erythematosus	4.57e-05	0.000281	CbGpPWpGaD
Irbesartan—EDNRA—Signaling by GPCR—CCR5—systemic lupus erythematosus	4.56e-05	0.00028	CbGpPWpGaD
Irbesartan—EDNRA—Signaling by GPCR—IL2RA—systemic lupus erythematosus	4.49e-05	0.000276	CbGpPWpGaD
Irbesartan—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TGFB1—systemic lupus erythematosus	4.48e-05	0.000275	CbGpPWpGaD
Irbesartan—PTGS1—Selenium Micronutrient Network—IL6—systemic lupus erythematosus	4.47e-05	0.000275	CbGpPWpGaD
Irbesartan—JUN—Immune System—NCF2—systemic lupus erythematosus	4.45e-05	0.000274	CbGpPWpGaD
Irbesartan—EDNRA—Signaling by GPCR—C3—systemic lupus erythematosus	4.45e-05	0.000273	CbGpPWpGaD
Irbesartan—JUN—Regulation of toll-like receptor signaling pathway—IL6—systemic lupus erythematosus	4.44e-05	0.000273	CbGpPWpGaD
Irbesartan—JUN—Immune System—LYN—systemic lupus erythematosus	4.42e-05	0.000272	CbGpPWpGaD
Irbesartan—JUN—Innate Immune System—JAK1—systemic lupus erythematosus	4.42e-05	0.000272	CbGpPWpGaD
Irbesartan—JUN—Toll-Like Receptors Cascades—IL6—systemic lupus erythematosus	4.39e-05	0.00027	CbGpPWpGaD
Irbesartan—JUN—Immune System—FCGR2A—systemic lupus erythematosus	4.37e-05	0.000268	CbGpPWpGaD
Irbesartan—CYP1A2—Biological oxidations—RXRA—systemic lupus erythematosus	4.34e-05	0.000267	CbGpPWpGaD
Irbesartan—AGTR1—Signaling Pathways—HIST2H2AC—systemic lupus erythematosus	4.32e-05	0.000266	CbGpPWpGaD
Irbesartan—EDNRA—GPCR downstream signaling—F2—systemic lupus erythematosus	4.3e-05	0.000264	CbGpPWpGaD
Irbesartan—JUN—Immune System—TNFAIP3—systemic lupus erythematosus	4.29e-05	0.000263	CbGpPWpGaD
Irbesartan—JUN—Integrated Pancreatic Cancer Pathway—TNF—systemic lupus erythematosus	4.27e-05	0.000262	CbGpPWpGaD
Irbesartan—JUN—Cellular responses to stress—CDKN1A—systemic lupus erythematosus	4.27e-05	0.000262	CbGpPWpGaD
Irbesartan—JUN—Immune System—BLK—systemic lupus erythematosus	4.24e-05	0.00026	CbGpPWpGaD
Irbesartan—AGTR1—Signaling Pathways—CSK—systemic lupus erythematosus	4.21e-05	0.000259	CbGpPWpGaD
Irbesartan—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—systemic lupus erythematosus	4.19e-05	0.000258	CbGpPWpGaD
Irbesartan—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—systemic lupus erythematosus	4.18e-05	0.000257	CbGpPWpGaD
Irbesartan—CYP1A2—Aryl Hydrocarbon Receptor—TNF—systemic lupus erythematosus	4.18e-05	0.000257	CbGpPWpGaD
Irbesartan—AGTR1—GPCR downstream signaling—JAK1—systemic lupus erythematosus	4.15e-05	0.000255	CbGpPWpGaD
Irbesartan—JUN—Innate Immune System—C3—systemic lupus erythematosus	4.09e-05	0.000251	CbGpPWpGaD
Irbesartan—JUN—Myometrial Relaxation and Contraction Pathways—IL6—systemic lupus erythematosus	4.07e-05	0.00025	CbGpPWpGaD
Irbesartan—JUN—Cellular responses to stress—EP300—systemic lupus erythematosus	4.06e-05	0.000249	CbGpPWpGaD
Irbesartan—JUN—SIDS Susceptibility Pathways—IL6—systemic lupus erythematosus	4.05e-05	0.000249	CbGpPWpGaD
Irbesartan—AGTR1—GPCR downstream signaling—CCR5—systemic lupus erythematosus	3.94e-05	0.000242	CbGpPWpGaD
Irbesartan—EDNRA—Signaling Pathways—CXCL12—systemic lupus erythematosus	3.93e-05	0.000241	CbGpPWpGaD
Irbesartan—EDNRA—Signaling by GPCR—F2—systemic lupus erythematosus	3.91e-05	0.00024	CbGpPWpGaD
Irbesartan—JUN—Innate Immune System—CRP—systemic lupus erythematosus	3.89e-05	0.000239	CbGpPWpGaD
Irbesartan—AGTR1—GPCR downstream signaling—IL2RA—systemic lupus erythematosus	3.88e-05	0.000238	CbGpPWpGaD
Irbesartan—EDNRA—Signaling Pathways—JUNB—systemic lupus erythematosus	3.85e-05	0.000237	CbGpPWpGaD
Irbesartan—AGTR1—Signaling Pathways—NCF2—systemic lupus erythematosus	3.85e-05	0.000237	CbGpPWpGaD
Irbesartan—AGTR1—GPCR downstream signaling—C3—systemic lupus erythematosus	3.85e-05	0.000236	CbGpPWpGaD
Irbesartan—JUN—Cellular responses to stress—VEGFA—systemic lupus erythematosus	3.84e-05	0.000236	CbGpPWpGaD
Irbesartan—AGTR1—Signaling Pathways—LYN—systemic lupus erythematosus	3.83e-05	0.000235	CbGpPWpGaD
Irbesartan—JUN—Immune System—PTPRC—systemic lupus erythematosus	3.79e-05	0.000233	CbGpPWpGaD
Irbesartan—AGTR1—Signaling by GPCR—JAK1—systemic lupus erythematosus	3.77e-05	0.000232	CbGpPWpGaD
Irbesartan—JUN—Immune System—IL1RN—systemic lupus erythematosus	3.77e-05	0.000232	CbGpPWpGaD
Irbesartan—AGTR1—Signaling Pathways—SH2B3—systemic lupus erythematosus	3.76e-05	0.000231	CbGpPWpGaD
Irbesartan—JUN—Innate Immune System—TLR4—systemic lupus erythematosus	3.73e-05	0.000229	CbGpPWpGaD
Irbesartan—PTGS1—Metabolism of lipids and lipoproteins—RXRA—systemic lupus erythematosus	3.71e-05	0.000228	CbGpPWpGaD
Irbesartan—JUN—Fc epsilon receptor (FCERI) signaling—IL6—systemic lupus erythematosus	3.66e-05	0.000225	CbGpPWpGaD
Irbesartan—EDNRA—Signaling Pathways—RASGRP1—systemic lupus erythematosus	3.66e-05	0.000225	CbGpPWpGaD
Irbesartan—AGTR1—Signaling by GPCR—CCR5—systemic lupus erythematosus	3.57e-05	0.00022	CbGpPWpGaD
Irbesartan—EDNRA—Signaling Pathways—PRL—systemic lupus erythematosus	3.55e-05	0.000218	CbGpPWpGaD
Irbesartan—JUN—Signaling Pathways—TLR9—systemic lupus erythematosus	3.53e-05	0.000217	CbGpPWpGaD
Irbesartan—AGTR1—Signaling by GPCR—IL2RA—systemic lupus erythematosus	3.52e-05	0.000216	CbGpPWpGaD
Irbesartan—JUN—Immune System—CD40—systemic lupus erythematosus	3.52e-05	0.000216	CbGpPWpGaD
Irbesartan—JUN—Cellular Senescence—IL6—systemic lupus erythematosus	3.52e-05	0.000216	CbGpPWpGaD
Irbesartan—AGTR1—Signaling by GPCR—C3—systemic lupus erythematosus	3.49e-05	0.000215	CbGpPWpGaD
Irbesartan—EDNRA—Signaling by GPCR—CCL2—systemic lupus erythematosus	3.48e-05	0.000214	CbGpPWpGaD
Irbesartan—JUN—Immune System—CTLA4—systemic lupus erythematosus	3.47e-05	0.000213	CbGpPWpGaD
Irbesartan—JUN—Immune System—HMGB1—systemic lupus erythematosus	3.47e-05	0.000213	CbGpPWpGaD
Irbesartan—JUN—Innate Immune System—CD80—systemic lupus erythematosus	3.45e-05	0.000212	CbGpPWpGaD
Irbesartan—JUN—Signaling Pathways—P2RY12—systemic lupus erythematosus	3.42e-05	0.00021	CbGpPWpGaD
Irbesartan—JUN—Immune System—IFNA1—systemic lupus erythematosus	3.41e-05	0.000209	CbGpPWpGaD
Irbesartan—AGTR1—GPCR downstream signaling—F2—systemic lupus erythematosus	3.38e-05	0.000207	CbGpPWpGaD
Irbesartan—CYP3A4—Biological oxidations—RXRA—systemic lupus erythematosus	3.35e-05	0.000206	CbGpPWpGaD
Irbesartan—JUN—Immune System—RASGRP1—systemic lupus erythematosus	3.32e-05	0.000204	CbGpPWpGaD
Irbesartan—JUN—Immune System—CD79A—systemic lupus erythematosus	3.31e-05	0.000203	CbGpPWpGaD
Irbesartan—JUN—Circadian rythm related genes—IL6—systemic lupus erythematosus	3.31e-05	0.000203	CbGpPWpGaD
Irbesartan—JUN—Signaling Pathways—HIST2H2AC—systemic lupus erythematosus	3.23e-05	0.000198	CbGpPWpGaD
Irbesartan—JUN—Immune System—PRL—systemic lupus erythematosus	3.22e-05	0.000198	CbGpPWpGaD
Irbesartan—EDNRA—Signaling by GPCR—TYK2—systemic lupus erythematosus	3.16e-05	0.000194	CbGpPWpGaD
Irbesartan—JUN—Signaling Pathways—CSK—systemic lupus erythematosus	3.15e-05	0.000193	CbGpPWpGaD
Irbesartan—AGTR1—Signaling Pathways—CXCL12—systemic lupus erythematosus	3.08e-05	0.000189	CbGpPWpGaD
Irbesartan—AGTR1—Signaling by GPCR—F2—systemic lupus erythematosus	3.07e-05	0.000188	CbGpPWpGaD
Irbesartan—JUN—Immune System—HLA-DQA1—systemic lupus erythematosus	3.05e-05	0.000188	CbGpPWpGaD
Irbesartan—AGTR1—Signaling Pathways—JUNB—systemic lupus erythematosus	3.02e-05	0.000186	CbGpPWpGaD
Irbesartan—PTGS1—Metabolism—NAT2—systemic lupus erythematosus	2.95e-05	0.000181	CbGpPWpGaD
Irbesartan—UGT1A3—Metabolism—RXRA—systemic lupus erythematosus	2.93e-05	0.00018	CbGpPWpGaD
Irbesartan—JUN—Innate Immune System—TYK2—systemic lupus erythematosus	2.91e-05	0.000179	CbGpPWpGaD
Irbesartan—EDNRA—GPCR downstream signaling—IL2—systemic lupus erythematosus	2.9e-05	0.000178	CbGpPWpGaD
Irbesartan—JUN—Signaling Pathways—NCF2—systemic lupus erythematosus	2.88e-05	0.000177	CbGpPWpGaD
Irbesartan—AGTR1—Signaling Pathways—RASGRP1—systemic lupus erythematosus	2.87e-05	0.000177	CbGpPWpGaD
Irbesartan—JUN—Signaling Pathways—LYN—systemic lupus erythematosus	2.86e-05	0.000176	CbGpPWpGaD
Irbesartan—JUN—Immune System—HLA-DQB1—systemic lupus erythematosus	2.86e-05	0.000175	CbGpPWpGaD
Irbesartan—EDNRA—Signaling Pathways—JAK1—systemic lupus erythematosus	2.84e-05	0.000174	CbGpPWpGaD
Irbesartan—JUN—Signaling Pathways—SH2B3—systemic lupus erythematosus	2.81e-05	0.000172	CbGpPWpGaD
Irbesartan—AGTR1—Signaling Pathways—PRL—systemic lupus erythematosus	2.79e-05	0.000171	CbGpPWpGaD
Irbesartan—AGTR1—Signaling by GPCR—CCL2—systemic lupus erythematosus	2.73e-05	0.000168	CbGpPWpGaD
Irbesartan—JUN—Immune System—IL18—systemic lupus erythematosus	2.71e-05	0.000166	CbGpPWpGaD
Irbesartan—JUN—Immune System—CD40LG—systemic lupus erythematosus	2.7e-05	0.000166	CbGpPWpGaD
Irbesartan—EDNRA—Signaling Pathways—CCR5—systemic lupus erythematosus	2.69e-05	0.000165	CbGpPWpGaD
Irbesartan—JUN—Immune System—CD8A—systemic lupus erythematosus	2.67e-05	0.000164	CbGpPWpGaD
Irbesartan—JUN—Cellular responses to stress—IL6—systemic lupus erythematosus	2.66e-05	0.000163	CbGpPWpGaD
Irbesartan—EDNRA—Signaling Pathways—IL2RA—systemic lupus erythematosus	2.65e-05	0.000163	CbGpPWpGaD
Irbesartan—EDNRA—Signaling by GPCR—IL2—systemic lupus erythematosus	2.63e-05	0.000162	CbGpPWpGaD
Irbesartan—JUN—Innate Immune System—CD4—systemic lupus erythematosus	2.63e-05	0.000162	CbGpPWpGaD
Irbesartan—EDNRA—Signaling Pathways—C3—systemic lupus erythematosus	2.63e-05	0.000162	CbGpPWpGaD
Irbesartan—JUN—Immune System—JAK1—systemic lupus erythematosus	2.57e-05	0.000158	CbGpPWpGaD
Irbesartan—AGTR1—Signaling by GPCR—TYK2—systemic lupus erythematosus	2.48e-05	0.000152	CbGpPWpGaD
Irbesartan—JUN—Innate Immune System—CDKN1B—systemic lupus erythematosus	2.47e-05	0.000152	CbGpPWpGaD
Irbesartan—JUN—Immune System—IL2RA—systemic lupus erythematosus	2.4e-05	0.000148	CbGpPWpGaD
Irbesartan—CYP2C8—Metabolism of lipids and lipoproteins—RXRA—systemic lupus erythematosus	2.4e-05	0.000147	CbGpPWpGaD
Irbesartan—JUN—Immune System—C3—systemic lupus erythematosus	2.38e-05	0.000146	CbGpPWpGaD
Irbesartan—PTGS1—Metabolism of lipids and lipoproteins—PPARG—systemic lupus erythematosus	2.34e-05	0.000144	CbGpPWpGaD
Irbesartan—EDNRA—Signaling Pathways—F2—systemic lupus erythematosus	2.31e-05	0.000142	CbGpPWpGaD
Irbesartan—JUN—Signaling Pathways—CXCL12—systemic lupus erythematosus	2.3e-05	0.000141	CbGpPWpGaD
Irbesartan—JUN—Innate Immune System—CDKN1A—systemic lupus erythematosus	2.28e-05	0.00014	CbGpPWpGaD
Irbesartan—AGTR1—GPCR downstream signaling—IL2—systemic lupus erythematosus	2.27e-05	0.00014	CbGpPWpGaD
Irbesartan—JUN—Immune System—CRP—systemic lupus erythematosus	2.27e-05	0.000139	CbGpPWpGaD
Irbesartan—JUN—Signaling Pathways—JUNB—systemic lupus erythematosus	2.26e-05	0.000139	CbGpPWpGaD
Irbesartan—AGTR1—Signaling Pathways—JAK1—systemic lupus erythematosus	2.23e-05	0.000137	CbGpPWpGaD
Irbesartan—EDNRA—Signaling Pathways—CD80—systemic lupus erythematosus	2.21e-05	0.000136	CbGpPWpGaD
Irbesartan—JUN—Immune System—TLR4—systemic lupus erythematosus	2.17e-05	0.000134	CbGpPWpGaD
Irbesartan—JUN—Immune System—HLA-DRB1—systemic lupus erythematosus	2.17e-05	0.000133	CbGpPWpGaD
Irbesartan—JUN—Innate Immune System—EP300—systemic lupus erythematosus	2.17e-05	0.000133	CbGpPWpGaD
Irbesartan—JUN—Signaling Pathways—RASGRP1—systemic lupus erythematosus	2.15e-05	0.000132	CbGpPWpGaD
Irbesartan—AGTR1—Signaling Pathways—CCR5—systemic lupus erythematosus	2.11e-05	0.00013	CbGpPWpGaD
Irbesartan—PTGS1—Metabolism of lipids and lipoproteins—ALB—systemic lupus erythematosus	2.11e-05	0.000129	CbGpPWpGaD
Irbesartan—JUN—Signaling Pathways—PRL—systemic lupus erythematosus	2.08e-05	0.000128	CbGpPWpGaD
Irbesartan—AGTR1—Signaling Pathways—IL2RA—systemic lupus erythematosus	2.08e-05	0.000128	CbGpPWpGaD
Irbesartan—AGTR1—Signaling by GPCR—IL2—systemic lupus erythematosus	2.07e-05	0.000127	CbGpPWpGaD
Irbesartan—AGTR1—Signaling Pathways—C3—systemic lupus erythematosus	2.06e-05	0.000127	CbGpPWpGaD
Irbesartan—EDNRA—Signaling Pathways—CCL2—systemic lupus erythematosus	2.06e-05	0.000126	CbGpPWpGaD
Irbesartan—JUN—Immune System—CD80—systemic lupus erythematosus	2.01e-05	0.000123	CbGpPWpGaD
Irbesartan—CYP2C9—Metabolism of lipids and lipoproteins—RXRA—systemic lupus erythematosus	1.95e-05	0.00012	CbGpPWpGaD
Irbesartan—CYP2C8—Metabolism—NAT2—systemic lupus erythematosus	1.9e-05	0.000117	CbGpPWpGaD
Irbesartan—EDNRA—Signaling Pathways—TYK2—systemic lupus erythematosus	1.87e-05	0.000115	CbGpPWpGaD
Irbesartan—UGT1A3—Metabolism—PPARG—systemic lupus erythematosus	1.85e-05	0.000114	CbGpPWpGaD
Irbesartan—PTGS1—Metabolism of lipids and lipoproteins—PTGS2—systemic lupus erythematosus	1.84e-05	0.000113	CbGpPWpGaD
Irbesartan—EDNRA—Signaling Pathways—NOS3—systemic lupus erythematosus	1.83e-05	0.000113	CbGpPWpGaD
Irbesartan—AGTR1—Signaling Pathways—F2—systemic lupus erythematosus	1.81e-05	0.000111	CbGpPWpGaD
Irbesartan—AGTR1—Signaling Pathways—CD80—systemic lupus erythematosus	1.74e-05	0.000107	CbGpPWpGaD
Irbesartan—JUN—Immune System—TYK2—systemic lupus erythematosus	1.69e-05	0.000104	CbGpPWpGaD
Irbesartan—CYP1A2—Metabolism of lipids and lipoproteins—RXRA—systemic lupus erythematosus	1.67e-05	0.000102	CbGpPWpGaD
Irbesartan—UGT1A3—Metabolism—ALB—systemic lupus erythematosus	1.67e-05	0.000102	CbGpPWpGaD
Irbesartan—JUN—Signaling Pathways—JAK1—systemic lupus erythematosus	1.66e-05	0.000102	CbGpPWpGaD
Irbesartan—PTGS1—Metabolism—RXRA—systemic lupus erythematosus	1.65e-05	0.000102	CbGpPWpGaD
Irbesartan—AGTR1—Signaling Pathways—CCL2—systemic lupus erythematosus	1.61e-05	9.92e-05	CbGpPWpGaD
Irbesartan—UGT1A3—Metabolism—NOS3—systemic lupus erythematosus	1.59e-05	9.79e-05	CbGpPWpGaD
Irbesartan—EDNRA—Signaling Pathways—CDKN1B—systemic lupus erythematosus	1.59e-05	9.76e-05	CbGpPWpGaD
Irbesartan—JUN—Immune System—IFNG—systemic lupus erythematosus	1.59e-05	9.75e-05	CbGpPWpGaD
Irbesartan—JUN—Signaling Pathways—CCR5—systemic lupus erythematosus	1.58e-05	9.69e-05	CbGpPWpGaD
Irbesartan—CYP2D6—Metabolism—NAT2—systemic lupus erythematosus	1.56e-05	9.6e-05	CbGpPWpGaD
Irbesartan—EDNRA—Signaling Pathways—IL2—systemic lupus erythematosus	1.55e-05	9.55e-05	CbGpPWpGaD
Irbesartan—JUN—Signaling Pathways—IL2RA—systemic lupus erythematosus	1.55e-05	9.55e-05	CbGpPWpGaD
Irbesartan—CYP2C9—Metabolism—NAT2—systemic lupus erythematosus	1.55e-05	9.52e-05	CbGpPWpGaD
Irbesartan—EDNRA—Signaling by GPCR—IL6—systemic lupus erythematosus	1.55e-05	9.5e-05	CbGpPWpGaD
Irbesartan—JUN—Signaling Pathways—C3—systemic lupus erythematosus	1.54e-05	9.47e-05	CbGpPWpGaD
Irbesartan—PTGS1—Metabolism of lipids and lipoproteins—EP300—systemic lupus erythematosus	1.53e-05	9.42e-05	CbGpPWpGaD
Irbesartan—JUN—Immune System—CD4—systemic lupus erythematosus	1.53e-05	9.41e-05	CbGpPWpGaD
Irbesartan—CYP2C8—Metabolism of lipids and lipoproteins—PPARG—systemic lupus erythematosus	1.51e-05	9.3e-05	CbGpPWpGaD
Irbesartan—EDNRA—Signaling Pathways—MMP9—systemic lupus erythematosus	1.47e-05	9.04e-05	CbGpPWpGaD
Irbesartan—EDNRA—Signaling Pathways—CDKN1A—systemic lupus erythematosus	1.47e-05	9.01e-05	CbGpPWpGaD
Irbesartan—AGTR1—Signaling Pathways—TYK2—systemic lupus erythematosus	1.47e-05	9.01e-05	CbGpPWpGaD
Irbesartan—UGT1A3—Metabolism—PTGS2—systemic lupus erythematosus	1.46e-05	8.95e-05	CbGpPWpGaD
Irbesartan—JUN—Immune System—CDKN1B—systemic lupus erythematosus	1.44e-05	8.85e-05	CbGpPWpGaD
Irbesartan—AGTR1—Signaling Pathways—NOS3—systemic lupus erythematosus	1.44e-05	8.84e-05	CbGpPWpGaD
Irbesartan—JUN—Innate Immune System—IL6—systemic lupus erythematosus	1.42e-05	8.74e-05	CbGpPWpGaD
Irbesartan—JUN—Immune System—IL2—systemic lupus erythematosus	1.41e-05	8.66e-05	CbGpPWpGaD
Irbesartan—EDNRA—Signaling Pathways—EP300—systemic lupus erythematosus	1.4e-05	8.57e-05	CbGpPWpGaD
Irbesartan—CYP2C8—Metabolism of lipids and lipoproteins—ALB—systemic lupus erythematosus	1.36e-05	8.36e-05	CbGpPWpGaD
Irbesartan—JUN—Signaling Pathways—F2—systemic lupus erythematosus	1.35e-05	8.31e-05	CbGpPWpGaD
Irbesartan—JUN—Immune System—CDKN1A—systemic lupus erythematosus	1.33e-05	8.17e-05	CbGpPWpGaD
Irbesartan—CYP1A2—Metabolism—NAT2—systemic lupus erythematosus	1.32e-05	8.14e-05	CbGpPWpGaD
Irbesartan—EDNRA—Signaling Pathways—VEGFA—systemic lupus erythematosus	1.32e-05	8.12e-05	CbGpPWpGaD
Irbesartan—JUN—Signaling Pathways—CD80—systemic lupus erythematosus	1.3e-05	7.97e-05	CbGpPWpGaD
Irbesartan—JUN—Immune System—EP300—systemic lupus erythematosus	1.26e-05	7.77e-05	CbGpPWpGaD
Irbesartan—AGTR1—Signaling Pathways—CDKN1B—systemic lupus erythematosus	1.25e-05	7.66e-05	CbGpPWpGaD
Irbesartan—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—systemic lupus erythematosus	1.23e-05	7.57e-05	CbGpPWpGaD
Irbesartan—AGTR1—Signaling Pathways—IL2—systemic lupus erythematosus	1.22e-05	7.49e-05	CbGpPWpGaD
Irbesartan—AGTR1—Signaling by GPCR—IL6—systemic lupus erythematosus	1.21e-05	7.46e-05	CbGpPWpGaD
Irbesartan—EDNRA—Signaling Pathways—TGFB1—systemic lupus erythematosus	1.21e-05	7.45e-05	CbGpPWpGaD
Irbesartan—UGT1A3—Metabolism—EP300—systemic lupus erythematosus	1.21e-05	7.45e-05	CbGpPWpGaD
Irbesartan—JUN—Signaling Pathways—CCL2—systemic lupus erythematosus	1.21e-05	7.41e-05	CbGpPWpGaD
Irbesartan—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—systemic lupus erythematosus	1.19e-05	7.31e-05	CbGpPWpGaD
Irbesartan—AGTR1—Signaling Pathways—MMP9—systemic lupus erythematosus	1.15e-05	7.09e-05	CbGpPWpGaD
Irbesartan—AGTR1—Signaling Pathways—CDKN1A—systemic lupus erythematosus	1.15e-05	7.07e-05	CbGpPWpGaD
Irbesartan—CYP2C9—Metabolism of lipids and lipoproteins—ALB—systemic lupus erythematosus	1.11e-05	6.8e-05	CbGpPWpGaD
Irbesartan—JUN—Signaling Pathways—TYK2—systemic lupus erythematosus	1.1e-05	6.73e-05	CbGpPWpGaD
Irbesartan—AGTR1—Signaling Pathways—EP300—systemic lupus erythematosus	1.09e-05	6.72e-05	CbGpPWpGaD
Irbesartan—JUN—Signaling Pathways—NOS3—systemic lupus erythematosus	1.08e-05	6.6e-05	CbGpPWpGaD
Irbesartan—CYP2C8—Metabolism—RXRA—systemic lupus erythematosus	1.07e-05	6.56e-05	CbGpPWpGaD
Irbesartan—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—systemic lupus erythematosus	1.05e-05	6.47e-05	CbGpPWpGaD
Irbesartan—PTGS1—Metabolism—PPARG—systemic lupus erythematosus	1.04e-05	6.41e-05	CbGpPWpGaD
Irbesartan—AGTR1—Signaling Pathways—VEGFA—systemic lupus erythematosus	1.04e-05	6.37e-05	CbGpPWpGaD
Irbesartan—CYP3A4—Metabolism—NAT2—systemic lupus erythematosus	1.02e-05	6.28e-05	CbGpPWpGaD
Irbesartan—CYP2C8—Metabolism of lipids and lipoproteins—EP300—systemic lupus erythematosus	9.9e-06	6.08e-05	CbGpPWpGaD
Irbesartan—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—systemic lupus erythematosus	9.69e-06	5.95e-05	CbGpPWpGaD
Irbesartan—AGTR1—Signaling Pathways—TGFB1—systemic lupus erythematosus	9.52e-06	5.85e-05	CbGpPWpGaD
Irbesartan—CYP1A2—Metabolism of lipids and lipoproteins—ALB—systemic lupus erythematosus	9.47e-06	5.81e-05	CbGpPWpGaD
Irbesartan—PTGS1—Metabolism—ALB—systemic lupus erythematosus	9.38e-06	5.76e-05	CbGpPWpGaD
Irbesartan—JUN—Signaling Pathways—CDKN1B—systemic lupus erythematosus	9.31e-06	5.72e-05	CbGpPWpGaD
Irbesartan—EDNRA—Signaling Pathways—IL6—systemic lupus erythematosus	9.14e-06	5.61e-05	CbGpPWpGaD
Irbesartan—JUN—Signaling Pathways—IL2—systemic lupus erythematosus	9.11e-06	5.6e-05	CbGpPWpGaD
Irbesartan—PTGS1—Metabolism—NOS3—systemic lupus erythematosus	8.98e-06	5.51e-05	CbGpPWpGaD
Irbesartan—CYP2D6—Metabolism—RXRA—systemic lupus erythematosus	8.77e-06	5.38e-05	CbGpPWpGaD
Irbesartan—CYP2C9—Metabolism—RXRA—systemic lupus erythematosus	8.69e-06	5.34e-05	CbGpPWpGaD
Irbesartan—JUN—Signaling Pathways—MMP9—systemic lupus erythematosus	8.63e-06	5.3e-05	CbGpPWpGaD
Irbesartan—JUN—Signaling Pathways—CDKN1A—systemic lupus erythematosus	8.6e-06	5.28e-05	CbGpPWpGaD
Irbesartan—JUN—Immune System—IL6—systemic lupus erythematosus	8.29e-06	5.09e-05	CbGpPWpGaD
Irbesartan—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—systemic lupus erythematosus	8.28e-06	5.09e-05	CbGpPWpGaD
Irbesartan—PTGS1—Metabolism—PTGS2—systemic lupus erythematosus	8.21e-06	5.04e-05	CbGpPWpGaD
Irbesartan—JUN—Signaling Pathways—EP300—systemic lupus erythematosus	8.18e-06	5.02e-05	CbGpPWpGaD
Irbesartan—CYP2C9—Metabolism of lipids and lipoproteins—EP300—systemic lupus erythematosus	8.06e-06	4.95e-05	CbGpPWpGaD
Irbesartan—JUN—Signaling Pathways—VEGFA—systemic lupus erythematosus	7.75e-06	4.76e-05	CbGpPWpGaD
Irbesartan—CYP1A2—Metabolism—RXRA—systemic lupus erythematosus	7.43e-06	4.56e-05	CbGpPWpGaD
Irbesartan—AGTR1—Signaling Pathways—IL6—systemic lupus erythematosus	7.17e-06	4.41e-05	CbGpPWpGaD
Irbesartan—JUN—Signaling Pathways—TGFB1—systemic lupus erythematosus	7.11e-06	4.37e-05	CbGpPWpGaD
Irbesartan—CYP1A2—Metabolism of lipids and lipoproteins—EP300—systemic lupus erythematosus	6.89e-06	4.23e-05	CbGpPWpGaD
Irbesartan—PTGS1—Metabolism—EP300—systemic lupus erythematosus	6.83e-06	4.19e-05	CbGpPWpGaD
Irbesartan—CYP2C8—Metabolism—PPARG—systemic lupus erythematosus	6.74e-06	4.14e-05	CbGpPWpGaD
Irbesartan—CYP2C8—Metabolism—ALB—systemic lupus erythematosus	6.06e-06	3.72e-05	CbGpPWpGaD
Irbesartan—CYP2C8—Metabolism—NOS3—systemic lupus erythematosus	5.8e-06	3.56e-05	CbGpPWpGaD
Irbesartan—CYP3A4—Metabolism—RXRA—systemic lupus erythematosus	5.73e-06	3.52e-05	CbGpPWpGaD
Irbesartan—CYP2D6—Metabolism—PPARG—systemic lupus erythematosus	5.53e-06	3.4e-05	CbGpPWpGaD
Irbesartan—CYP2C9—Metabolism—PPARG—systemic lupus erythematosus	5.49e-06	3.37e-05	CbGpPWpGaD
Irbesartan—JUN—Signaling Pathways—IL6—systemic lupus erythematosus	5.36e-06	3.29e-05	CbGpPWpGaD
Irbesartan—CYP2C8—Metabolism—PTGS2—systemic lupus erythematosus	5.3e-06	3.26e-05	CbGpPWpGaD
Irbesartan—CYP2D6—Metabolism—ALB—systemic lupus erythematosus	4.98e-06	3.06e-05	CbGpPWpGaD
Irbesartan—CYP2C9—Metabolism—ALB—systemic lupus erythematosus	4.93e-06	3.03e-05	CbGpPWpGaD
Irbesartan—CYP2D6—Metabolism—NOS3—systemic lupus erythematosus	4.76e-06	2.92e-05	CbGpPWpGaD
Irbesartan—CYP2C9—Metabolism—NOS3—systemic lupus erythematosus	4.72e-06	2.9e-05	CbGpPWpGaD
Irbesartan—CYP1A2—Metabolism—PPARG—systemic lupus erythematosus	4.69e-06	2.88e-05	CbGpPWpGaD
Irbesartan—CYP2C8—Metabolism—EP300—systemic lupus erythematosus	4.41e-06	2.71e-05	CbGpPWpGaD
Irbesartan—CYP2D6—Metabolism—PTGS2—systemic lupus erythematosus	4.35e-06	2.67e-05	CbGpPWpGaD
Irbesartan—CYP2C9—Metabolism—PTGS2—systemic lupus erythematosus	4.32e-06	2.65e-05	CbGpPWpGaD
Irbesartan—CYP1A2—Metabolism—ALB—systemic lupus erythematosus	4.22e-06	2.59e-05	CbGpPWpGaD
Irbesartan—CYP1A2—Metabolism—NOS3—systemic lupus erythematosus	4.03e-06	2.48e-05	CbGpPWpGaD
Irbesartan—CYP1A2—Metabolism—PTGS2—systemic lupus erythematosus	3.69e-06	2.27e-05	CbGpPWpGaD
Irbesartan—CYP2D6—Metabolism—EP300—systemic lupus erythematosus	3.62e-06	2.22e-05	CbGpPWpGaD
Irbesartan—CYP3A4—Metabolism—PPARG—systemic lupus erythematosus	3.62e-06	2.22e-05	CbGpPWpGaD
Irbesartan—CYP2C9—Metabolism—EP300—systemic lupus erythematosus	3.59e-06	2.21e-05	CbGpPWpGaD
Irbesartan—CYP3A4—Metabolism—ALB—systemic lupus erythematosus	3.25e-06	2e-05	CbGpPWpGaD
Irbesartan—CYP3A4—Metabolism—NOS3—systemic lupus erythematosus	3.11e-06	1.91e-05	CbGpPWpGaD
Irbesartan—CYP1A2—Metabolism—EP300—systemic lupus erythematosus	3.07e-06	1.88e-05	CbGpPWpGaD
Irbesartan—CYP3A4—Metabolism—PTGS2—systemic lupus erythematosus	2.85e-06	1.75e-05	CbGpPWpGaD
Irbesartan—CYP3A4—Metabolism—EP300—systemic lupus erythematosus	2.37e-06	1.45e-05	CbGpPWpGaD
